tiprankstipranks
IQE PLC (GB:IQE)
LSE:IQE
UK Market
Want to see GB:IQE full AI Analyst Report?

IQE plc (IQE) AI Stock Analysis

156 Followers

Top Page

GB:IQE

IQE plc

(LSE:IQE)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
41.00 p
▲(715.11% Upside)
Action:Reiterated
Date:05/29/26
The score is held back primarily by weak financial performance (persistent losses, negative gross profit in 2025, and negative free cash flow alongside rising debt and falling equity). This is partially offset by strong technical momentum (price above key moving averages with positive MACD), while valuation remains challenging due to negative earnings and no dividend data.
Positive Factors
End-market exposure and product relevance
IQE serves structural growth end-markets (wireless RF, photonics, sensing) with specialized III-V epi-wafers. This end-market mix supports durable secular demand for high-performance materials as connectivity, datacenter optics, and sensing applications expand over multiple years.
Negative Factors
Profitability weakness
Negative gross profit indicates pricing pressure or elevated manufacturing costs undermining core unit economics. Persistent operating and net losses mean the business has not yet demonstrated sustainable margin recovery, limiting internal reinvestment and prolonging reliance on financing.
Read all positive and negative factors
Positive Factors
Negative Factors
End-market exposure and product relevance
IQE serves structural growth end-markets (wireless RF, photonics, sensing) with specialized III-V epi-wafers. This end-market mix supports durable secular demand for high-performance materials as connectivity, datacenter optics, and sensing applications expand over multiple years.
Read all positive factors

IQE plc (IQE) vs. iShares MSCI United Kingdom ETF (EWC)

IQE plc Business Overview & Revenue Model

Company Description
IQE Plc is a holding company, which engages in the research, design, development, manufacture, and sale of compound semiconductor materials. It operates through the following segments: Wireless, Photonics, and CMOS++. The Wireless segment includes...
How the Company Makes Money
IQE makes money primarily by supplying compound semiconductor epi-wafers and related wafer-engineering services to semiconductor device manufacturers. Revenue is generated through (1) sale of custom and standard epi-wafers produced using processes...

IQE plc Earnings Call Summary

Earnings Call Date:May 13, 2025
(Q4-2024)
|
% Change Since: |
Next Earnings Date:Sep 15, 2026
Earnings Call Sentiment Neutral
The earnings call outlined significant improvements in adjusted EBITDA and wireless revenue growth, driven by strategic partnerships and product developments. However, these positives were tempered by a decline in photonics revenue, challenging macroeconomic conditions, and ongoing financial constraints, indicating a mixed outlook.
Positive Updates
Adjusted EBITDA Improvement
Adjusted EBITDA improved significantly from £4.3 million to £8.2 million, reflecting decisive cost actions and increased efficiencies.
Negative Updates
Photonics Revenue Decline
Photonics segment revenue decreased by 16% to £49.9 million, due to softness in the 3D sensing and pixels market.
Read all updates
Q4-2024 Updates
Negative
Adjusted EBITDA Improvement
Adjusted EBITDA improved significantly from £4.3 million to £8.2 million, reflecting decisive cost actions and increased efficiencies.
Read all positive updates
Company Guidance
In the recent IQE full-year results presentation, CEO Jutta Meier emphasized the company's strategic focus on financial discipline and operational agility amidst a challenging macroeconomic environment. The company's revenue for fiscal year 2024 remained stable at £118 million, while adjusted EBITDA improved significantly from £4.3 million to £8.2 million, attributed to decisive cost actions and efficiency improvements. The strategic review aims to make IQE debt-free and allow further investments in growth sectors such as GaN power and display technologies. Despite a 16% decline in Photonics revenue, Wireless revenue increased by 25% to £67.3 million, driven by higher penetration into the Asian market and increased GaN sales for 5G infrastructure. The company's cash position was bolstered by a convertible loan note fundraise, resulting in cash and cash equivalents of £20.6 million at the end of Q1 2025. Looking ahead, IQE expects revenue and adjusted EBITDA for fiscal year 2025 to align with analyst forecasts, with improvements anticipated in the second half of the year, driven by AI-related demand and strategic initiatives.

IQE plc Financial Statement Overview

Summary
Financials remain pressured: revenue is only modestly higher over the last two years, profitability is weak with gross profit turning negative in 2025 and ongoing operating/net losses, and free cash flow is still negative despite improved operating cash flow in 2025. Balance-sheet risk is rising as debt increased while equity declined, reducing flexibility.
Income Statement
22
Negative
Balance Sheet
44
Neutral
Cash Flow
33
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue97.30M118.03M115.25M167.50M154.10M
Gross Profit-3.24M4.45M2.33M26.40M17.64M
EBITDA-507.00K-6.22M-1.11M-46.68M5.23M
Net Income-36.70M-38.18M-29.38M-74.50M-31.00M
Balance Sheet
Total Assets213.34M247.05M273.51M296.10M351.22M
Cash, Cash Equivalents and Short-Term Investments15.65M4.66M5.62M11.60M10.79M
Total Debt91.69M73.99M54.15M77.60M70.98M
Total Liabilities123.64M112.94M103.73M121.00M116.60M
Stockholders Equity89.69M134.11M169.78M175.10M234.62M
Cash Flow
Free Cash Flow-4.63M-17.72M-12.20M-12.00M-3.00M
Operating Cash Flow3.72M-2.88M5.92M5.90M15.39M
Investing Cash Flow-8.39M-10.19M-17.96M-10.70M-18.30M
Financing Cash Flow15.82M12.16M6.63M4.73M-11.17M

IQE plc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5.03
Price Trends
50DMA
46.44
Negative
100DMA
39.15
Negative
200DMA
22.86
Positive
Market Momentum
MACD
-2.39
Positive
RSI
41.75
Neutral
STOCH
37.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IQE, the sentiment is Negative. The current price of 5.03 is below the 20-day moving average (MA) of 45.11, below the 50-day MA of 46.44, and below the 200-day MA of 22.86, indicating a neutral trend. The MACD of -2.39 indicates Positive momentum. The RSI at 41.75 is Neutral, neither overbought nor oversold. The STOCH value of 37.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:IQE.

IQE plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
£57.40M4.3322.93%136.76%
67
Neutral
£235.94M59.253.33%2.19%12.73%-26.74%
63
Neutral
£613.64M62.7826.93%31.56%-4.41%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
59
Neutral
£44.43M262.002.29%3.67%-10.70%-200.00%
50
Neutral
£551.71M-10.19-37.49%-17.57%4.55%
46
Neutral
£5.11M5.1011.53%61.15%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:IQE
IQE plc
38.50
28.56
287.32%
GB:CML
CML Microsystems
262.00
-41.75
-13.74%
GB:FTC
Filtronic
285.00
119.00
71.69%
GB:GHH
Gooch & Housego
874.00
260.37
42.43%
GB:KMK
Kromek Group plc
8.40
2.95
54.13%
GB:NANO
Nanoco Group plc
2.65
-10.40
-79.69%

IQE plc Corporate Events

Business Operations and Strategy
IQE Wins $14m Multi-Year Order for AI and Datacentre Semiconductors
Positive
Jul 14, 2026
IQE plc has secured a multi-year $14 million production order from a strategic global technology customer, with manufacturing to take place at its Newport foundry in Wales. The wafers will support applications in artificial intelligence and datace...
Business Operations and StrategyRegulatory Filings and Compliance
IQE updates share capital position and expands employee share plan
Neutral
Jul 1, 2026
IQE plc reported that as of 30 June 2026 it had issued share capital of 1,331,036,951 ordinary shares, of which 4,115 are held in treasury, leaving 1,331,032,836 shares in issue with voting rights for investors to use in regulatory disclosure calc...
Business Operations and StrategyExecutive/Board Changes
IQE adds MACOM executives to board as strategic ties deepen
Positive
Jul 1, 2026
IQE plc has strengthened its board by appointing MACOM Technology Solutions executives Robert Dennehy and David O’Carroll as non-executive directors, in line with a previously agreed board appointment arrangement between the two companies. T...
Business Operations and StrategyShareholder Meetings
IQE shareholders back all resolutions at 2026 AGM
Positive
Jun 30, 2026
IQE plc reported that all resolutions proposed at its 2026 Annual General Meeting in London were approved by shareholders on a poll, with both ordinary and special resolutions passing by strong majorities. Voting participation represented just ove...
Regulatory Filings and ComplianceShareholder Meetings
IQE to Publish London AGM Results via Regulatory News Service
Neutral
Jun 30, 2026
IQE plc, the leading global supplier of compound semiconductor wafer products and advanced materials, will hold its Annual General Meeting today in London, with shareholders able to attend in person. The company will publish the AGM results via th...
Private Placements and Financing
IQE Director Exercises Warrants as Share Capital Rises to 1.32 Billion
Neutral
Jun 19, 2026
IQE plc has announced that non-executive director Bami Bastani has exercised warrants over 683,921 ordinary shares at an exercise price of 13.5 pence per share, with the new shares expected to be admitted to trading on AIM around 24 June 2026. Fol...
Delistings and Listing ChangesPrivate Placements and Financing
IQE Expands Share Capital Following Warrant Exercises
Neutral
Jun 16, 2026
IQE plc has received notices to exercise warrants over 5,864,624 ordinary shares at 13.5 pence, with the new stock set to be admitted to trading on AIM around 17 June, ranking equally with existing shares. The warrant exercises modestly expand IQE...
Business Operations and StrategyLegal Proceedings
IQE strikes multi-year InP supply pact with Tower Semiconductor and settles IP dispute
Positive
Jun 15, 2026
IQE has signed a multi-year agreement to supply indium phosphide epiwafers to Tower Semiconductor for use in silicon photonics platforms that underpin next-generation optical connectivity in AI-focused data centres. The deal includes minimum purch...
Business Operations and StrategyLegal Proceedings
IQE seals multi-year InP supply pact with Tower, settling IP dispute
Positive
Jun 15, 2026
IQE plc, a leading provider of compound semiconductor wafers, has signed a multi-year agreement to supply Indium Phosphide epiwafers to Tower Semiconductor for use in advanced silicon photonics platforms serving AI-driven data centre connectivity....
Executive/Board ChangesShareholder Meetings
IQE Director Victoria Hull to Step Down at June AGM
Neutral
Jun 10, 2026
IQE plc has announced that Independent Non-Executive Director Victoria Hull will not stand for re-election at the company’s Annual General Meeting on 30 June 2026 and will step down from the board at the close of that meeting. The resolution...
Financial DisclosuresShareholder Meetings
IQE Sets June AGM and Publishes 2025 Annual Report
Positive
Jun 3, 2026
IQE plc has published its Notice of Annual General Meeting for 2026 and scheduled the meeting for 30 June in London, with details on voting and shareholder questions available via its website. The group has also released its 2025 Annual Report and...
Regulatory Filings and Compliance
IQE updates total voting rights following share capital review
Neutral
Jun 2, 2026
IQE plc has confirmed that as of 1 June 2026 its issued share capital comprises 1,312,590,972 ordinary shares, of which 4,115 are held in treasury, leaving 1,312,586,857 ordinary shares carrying voting rights. This updated total voting rights figu...
Business Operations and StrategyPrivate Placements and Financing
IQE Directors Back Fundraising With Share Subscriptions and New Warrants
Positive
May 29, 2026
IQE plc has disclosed that chair Mark Cubitt and non-executive director Bami Bastani participated in the company’s recent equity fundraising, subscribing for 1,295,305 and 518,122 new ordinary shares respectively at 19.8 pence per share. Fol...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
IQE shores up balance sheet with £81m raise as AI photonics demand accelerates
Positive
May 28, 2026
IQE reported full-year 2025 revenue down 17.6% to £97.3m, as wireless sales were hit by weak handset demand and macroeconomic uncertainty, while photonics revenue rose 15% on defence and AI data-centre strength. Adjusted EBITDA fell to £...
Business Operations and StrategyExecutive/Board ChangesPrivate Placements and Financing
IQE Raises £81m and Expands Board as New Shares Join AIM
Positive
May 28, 2026
IQE plc has completed its previously announced fundraising, securing £81 million in aggregate proceeds and confirming that all conditions have been satisfied or waived, in a move that strengthens its balance sheet as demand for compound semic...
Business Operations and StrategyFinancial Disclosures
IQE sets date for full‑year 2025 results and investor webcast
Neutral
May 20, 2026
IQE plc has scheduled the release of its full‑year results for the 12 months to 31 December 2025 on 28 May 2026, with management set to brief investors via a webcast that morning. The announcement sets expectations for a forthcoming detailed...
Business Operations and StrategyShareholder Meetings
IQE Wins Strong Shareholder Backing for Expanded Share Issuance Authorities
Positive
May 15, 2026
IQE plc has secured strong shareholder backing at a London general meeting, where investors approved resolutions giving the board wider authority to allot new shares and issue additional equity securities. Both measures passed with more than 99% o...
Regulatory Filings and Compliance
IQE updates total voting rights following April share capital review
Neutral
May 1, 2026
IQE plc has confirmed that as of 30 April 2026 its issued share capital comprises 979,886,435 ordinary shares of 1 pence each, of which 4,115 are held in treasury, leaving 979,882,320 ordinary shares in issue with voting rights. The company highli...
Private Placements and FinancingShareholder Meetings
IQE Calls Shareholder Vote on Major Capital Raise to Avert Liquidity Squeeze
Negative
Apr 29, 2026
IQE plc has sent shareholders a circular convening a 15 May general meeting in London to approve resolutions underpinning its proposed capital raise, including authority to issue up to 407,941,253 new ordinary shares on both pre‑emptive and ...
Private Placements and FinancingRegulatory Filings and ComplianceShareholder Meetings
IQE Raises £81m in Conditional Fundraising Backed by Major Shareholders
Negative
Apr 28, 2026
IQE has completed a placing and retail offer, issuing more than 65 million new shares at 19.8 pence to raise £13 million, as part of a wider capital raise alongside a strategic MACOM investment and the reinvestment of convertible loan notes. ...
Business Operations and StrategyPrivate Placements and FinancingShareholder Meetings
IQE launches discounted UK retail share offer alongside wider fundraising
Positive
Apr 27, 2026
IQE has launched a conditional retail offer of new ordinary shares via platform provider RetailBook, giving existing UK retail shareholders the chance to subscribe at 19.8 pence per share, a 10.1% discount to the 12‑month VWAP and a steep di...
Business Operations and StrategyExecutive/Board ChangesPrivate Placements and Financing
IQE Secures £81m MACOM-Led Investment and Ends Strategic Review
Positive
Apr 27, 2026
IQE plc has secured a strategic investment from long‑standing customer MACOM Technology Solutions and other existing shareholders, raising approximately £81 million through a mix of equity, new convertible loan notes, a placing and a re...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 29, 2026